Glwl-01 capsule and placebo stability program. Manipulating ghrelin signaling via goat inhibition in alcohol use disorder testing
Ended Purchase Order Awarded Last action
- Contract number
- 75N95022P00407
- Awardee
-
Alcami Carolinas Corporation UEI D2DHUF4NTK23
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $71,114
Award facts
- Opportunity
-
- Manipulating Ghrelin signaling via GOAT inhibition in alcohol use disorder. Special Notice · 75N95022Q00400 · Posted Jul 12, 2022
- Contract value 83% obligated
-
- $71,114.00 Current, with exercised options
- $85,652.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Wilmington, NC 28405, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $15,236 | |
| Original award | $55,878 |
About this award
This is a firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Alcami Carolinas Corporation for a project titled "GLWL-01 CAPSULE AND PLACEBO STABILITY PROGRAM. MANIPULATING GHRELIN SIGNALING VIA GOAT INHIBITION IN ALCOHOL USE DISORDER TESTING". The contract has a ceiling value of $85,652.00 and a period of performance ending on August 4, 2025. The contract was awarded on a sole-source basis without a set-aside, as NIDA determined that Alcami Carolinas Corporation was the only reasonably available source. The contract is related to a special notice opportunity posted on July 12, 2022, with a due date of July 27, 2022.
Quick answers
Who was awarded contract 75N95022P00407?
75N95022P00407 was awarded to Alcami Carolinas Corporation by National Institute on Drug Abuse (National Institutes of Health) on August 5, 2022.
How much is contract 75N95022P00407 worth?
The government has obligated $71,114 on 75N95022P00407. Its potential value, with all options, is $85,652.
Was contract 75N95022P00407 competed?
The extent of competition for 75N95022P00407 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award